Centermed Krakow Sp. z o.o.
- Address
- lock Available on a paid plan
Dermatology and Immune-Mediated Skin Diseases
At Centermed Krakow Sp. z o.o., clinical research in Dermatology focuses strongly on skin and connective tissue diseases and immune system diseases, with studies centered on atopic dermatitis and alopecia areata. These trials are designed to assess new treatment options and better understand how to improve symptom control and long-term disease management.
- Testing new therapies for atopic dermatitis to improve disease control and reduce flare severity
- Evaluating treatment effectiveness and safety in alopecia areata
- Studying approaches that may offer more durable relief for chronic inflammatory skin conditions
The site’s dermatology program reflects a clear interest in treatments that may help patients with persistent, often relapsing skin disorders.
Musculoskeletal and Bone Health Research
Research at this site also covers musculoskeletal diseases and congenital, hereditary, and neonatal disorders, including osteogenesis imperfecta and knee osteoarthritis. The studies aim to evaluate whether new therapies can strengthen bone health, reduce pain, and improve mobility and quality of life.
- Assessing treatment options for osteogenesis imperfecta in children and adolescents
- Studying pain relief strategies for knee osteoarthritis
- Exploring therapies that may improve function in people with bone fragility or joint disease
These trials show a practical focus on both structural bone outcomes and everyday symptom improvement.
Digestive and Metabolic Disease Studies
The site is involved in trials across digestive system diseases and nutritional and metabolic diseases, especially Crohn's disease, idiopathic or diabetic gastroparesis, and overweight or obesity. This research is aimed at testing whether new treatments can better control inflammation, improve stomach emptying, and support weight reduction.
- Evaluating therapies for Crohn's disease to reduce active inflammation
- Studying treatment options for gastroparesis and delayed stomach emptying
- Investigating approaches for overweight or obesity with associated joint symptoms
These studies address both chronic gastrointestinal symptoms and broader metabolic health concerns.
Nervous System and Headache Research
Clinical trials at Centermed Krakow Sp. z o.o. also include nervous system diseases, with a focus on migraine headaches with or without aura. The main goal is to evaluate preventive treatments that may lower the frequency of migraine attacks and improve daily functioning for adults who have not responded well to earlier therapies.
- Testing migraine prevention strategies for adults with frequent headaches
- Assessing whether new options can reduce the number of migraine days per month
- Supporting better symptom control for patients with difficult-to-treat migraine
This area of research reflects a need for more effective long-term management of a common and disabling neurological condition.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 9 of 10 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novo Nordisk A/S2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S2trials
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centermed Krakow Sp. z o.o.
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, 24-week, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) | Amgen Inc. | Phase III | Not Recruiting | Apr 2023 | Jun 2025 |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Calcium | 1 | Unknown | 2023-11-20 | 2023-11-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.